Literature DB >> 1673432

Synergistic effect of interleukin 1 and soluble CD23 on the growth of human CD4+ bone marrow-derived T cells.

J M Bertho1, C Fourcade, A H Dalloul, P Debré, M D Mossalayi.   

Abstract

Low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is expressed by various human cells and known to be cleaved into soluble fragments (sCD23). Several biological activities were ascribed to these molecules. In this study, we have assessed the effect of recombinant 25-kDa sCD23 (rsCD23) on human bone marrow-derived T cells. Our results show that rsCD23 in synergy with recombinant interleukin 1 enhances mitogenic responsiveness of CD4+ T cells but does not affect CD8+ cell growth. Furthermore, rsCD23 synergizes autologous marrow cells in enhancement of CD4+ cell growth while CD23 monoclonal antibodies decrease accessory cell effect. Together, these data confirm cytokine-like activity of sCD23 on human T cell lineage.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1673432     DOI： 10.1002/eji.1830210433

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN： 0014-2980            Impact factor:   5.532


  9 in total

1.  Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells.

Authors:  S N Karagiannis; J K Warrack; K H Jennings; P R Murdock; G Christie; K Moulder; B J Sutton; H J Gould
Journal:  Immunology       Date:  2001-07       Impact factor: 7.397

Review 2.  CD23/FcεRII: molecular multi-tasking.

Authors:  M Acharya; G Borland; A L Edkins; L M Maclellan; J Matheson; B W Ozanne; W Cushley
Journal:  Clin Exp Immunol       Date:  2010-10       Impact factor: 4.330

Review 3.  CD23: novel disease marker with a split personality.

Authors:  J Gordon
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

4.  Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.

Authors:  A Katira; M Kamal; J Gordon
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

5.  Epidermal keratinocyte-derived basophil promoting activity. Role of interleukin 3 and soluble CD23.

Authors:  A H Dalloul; M Arock; C Fourcade; J Y Béranger; P Jaffray; P Debré; M D Mossalayi
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

6.  Native and recombinant soluble CD23 fragments with IgE suppressive activity.

Authors:  M Sarfati; B Bettler; M Letellier; S Fournier; M Rubio-Trujillo; H Hofstetter; G Delespesse
Journal:  Immunology       Date:  1992-08       Impact factor: 7.397

7.  Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes.

Authors:  S Pochon; P Graber; M Yeager; K Jansen; A R Bernard; J P Aubry; J Y Bonnefoy
Journal:  J Exp Med       Date:  1992-08-01       Impact factor: 14.307

8.  Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site.

Authors:  M D Mossalayi; M Arock; G Delespesse; H Hofstetter; B Bettler; A H Dalloul; E Kilchherr; F Quaaz; P Debré; M Sarfati
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

9.  Reviving lost binding sites: Exploring calcium-binding site transitions between human and murine CD23.

Authors:  Veronica F Ilkow; Anna M Davies; Balvinder Dhaliwal; Andrew J Beavil; Brian J Sutton; James M McDonnell
Journal:  FEBS Open Bio       Date:  2021-06-24       Impact factor: 2.792
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.